AUA 2015 Annual Meeting

Hyponatremia Lengthens Cancer Patient Hospital Stay

Timing of Maximum Tumor Shrinkage May Predict mRCC Pt Survival

NEW ORLEANS—The timing of maximum tumor shrinkage in patients with metastatic renal cell carcinoma (mRCC) may be useful as a biomarker for predicting overall survival, Japanese researchers reported at the 2015 American Urological Association annual meeting. Takafumi Yagisawa, MD, and colleagues at Tokyo Women’s Medical University, based this conclusion on a study of 199 mRCC…

Next post in AUA 2015 Prostate Cancer